Needham lowered the firm’s price target on Endava (DAVA) to $18 from $22 and keeps a Buy rating on the shares. The company’s Q3 results were mixed with a revenue miss due to weaker client demand, though its lower expenses helped boost margins and earnings, the analyst tells investors in a research note. The firm’s expectations for AI adoption to begin helping growth over the second half of 2025 and into 2026 make risk-reward favorable for SMID value investors, the firm added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAVA:
- Endava price target lowered to $25 from $28 at Guggenheim
- Endava price target lowered to $17 from $33 at Morgan Stanley
- Endava Reports Strong Q3 FY2025 Financial Results
- Endava’s Hold Rating: Navigating Challenges Amidst Macroeconomic Volatility and Limited Recovery Prospects
- Endava downgraded to Hold from Buy at TD Cowen